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Because the long-term anatomic effects of percutaneous
transluminal coronary angioplasty are unknown, follow-
up evaluations including coronary angiography, tread-
mill exercise testing and rest and bicycle exercise radio-
nuclide angiography were performed in 46 patients
6.3 ± 2.0 and 37.6 ± 3.6 (mean ± SD) months after
they had undergone successful single lesion angioplasty.
The severity of the coronary stenosis decreased signifi-
cantly at each evaluation; the mean diameter stenosis was
66 ± 13% before angioplasty, 30 ± 13% immediately
after and 26 ± 16% and 19 ± 13% at 6 months and 3
years, respectively. Exercise time increased from 9.8 ±
4.4 minutes before angioplasty to 18.3 ± 4.5 minutes
immediately after the procedure and remained at that
Since Griintzig et al. (I) introduced the technique of per-
cutaneous transluminal angioplasty in September 1977, it
has been shown that this procedure opens obstructed coro-
nary arteries in a high percentage of properly selected pa-
tients (l,2). Immediate symptomatic benefit occurs as a
result of the anatomic improvement (I), and electrocardio-
graphic (3) and radioisotope stress tests (3,4) have docu-
mented the improvement of effort tolerance and left ven-
tricular function with exercise.
Longer follow-up studies have described continued
symptomatic (2,5,6) and functional (3,6) benefits for up to
3 years after successful angioplasty. However, other than
the description of the occurrence of restenosis (7) and a
report of angiographic data in II (34%) of 32 of Gruntzig's
original patients (8), no anatomic long-term follow-up stud-
ies after a successful procedure are available. The present
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level at 6 months (20.3 ± 4.6 minutes) and 3 years
(18.2 ± 4.5 minutes).
Left ventricular ejection fraction during exercise de-
creased 4 ± 6% compared with rest before angioplasty,
but increased 7 ± 7% immediately after angioplasty and
this increase was maintained at 6 months (±6 ± 7%)
and 3 years (±4 ± 6%). Before angioplasty, 1 patient
was in Canadian Heart Association functional class 0,
15 were in class II, 24 in class III and 6 in class IV.
Three years later, 25 were in class 0, 10 in class I, 7 in
class II and 4 in class III. These results indicate that the
short-term anatomic and functional success of coronary
angioplasty is maintained for at least 3 years.
oAm Coil CardioI1987;9:1-7)
prospective investigation was designed to examine in a con-
secutive series of patients the results of anatomic studies
obtained by angiography at cardiac catheterization 6 months
and 3 years after a successful coronary angioplasty and to
correlate these results with functional stress testing,
Methods
Selection of patients. Between February 1979 and July
1981, we performed angioplasty procedures at the National
Institutes of Health on 108 coronary artery or saphenous
bypass graft lesions that produced 50% or greater diameter
narrowing in 104 consecutive patients, Sixty-seven (63%)
of these procedures in 65 patients were initially considered
to be successful by the criterion of an absolute improvement
of 20% in the degree of diameter stenosis. Three patients
with bypass graft dilations were excluded from the study
because of the inability to determine whether closure of a
graft was due to restenosis at the dilation site or to other
mechanisms that might cause graft closure. Three other
patients were not studied either 6 months or 3 years after
angioplasty. The remaining 59 patients were restudied within
0735-1097/87/$3.50
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the first year of angioplasty and 17 exhibited restenosis (a
loss of at least 50% of the gain achieved at angioplasty [7])
and underwent successful repeat angioplasty. Four of the
17 had a second restenosis but a third angioplasty was not
performed. Two other patients were not studied at 6 months
or 3 years after their second procedure . In II of the 17
patients whose restenosis had been identified by angiogra-
phy at a mean follow-up time of 4.9 months (range 2.5 to
9.5) , persistent angiographic improvement occurred at 6
month follow-up. All of these patients were symptomatic
at the time of their second procedure and, for purposes of
this study , the repeat angioplasty will be considered the
initial procedure. Thus, 53 patients exhibited persistent im-
pro'(ement of their dilated arteries at their 6 month study.
Of the 53 patients initially eligible for assessment of the
long-term results of coronary dilation, 8 (15%) were ex-
cluded: 6 patients who were not available for 3 year follow-
up study (including 1 who died of cardiac causes), I patient
with restenosis who had his last successful dilation per-
formed too recently to permit 3 year follow-up and I patient
who had a bypass graft placed distal to the dilation site.
Although the angioplasty site in this latter patient appeared
narrowed 7 months after coronary bypass and I year after
angioplasty , we could not determine whether this was due
to anatomic disease or to competitive flow. Thus, 45 patient s
with persistent improvement at 6 months underwent restudy
at 3 years . In addition, one patient who was asymptomatic
at the time ofour request for 6 month evaluation , and refused
catheterization at that time , requested evaluation at 3 years
because of the recurrence of chest pain and has been in-
cluded in this study .
Study patients. Of the 46 patients comprising the study
group, there were 33 men and 13 women, with an average
age of 52 years (range 34 to 69) . Thirty-eight patients had
significant disease only at the site of angioplasty, three pa-
tients had a second significant lesion in the vessel undergo-
ing coronary dilation or a branch thereof, for which dilation
was not attempted, four patients had a significant lesion in
another vessel for which angioplasty was not attempted and
one patient had triple vessel disease . The latter patient had
undergone coronary artery bypass surgery, and angioplasty
was performed 11 months postoperatively on his left main
coronary lesion. Angioplasty was performed on a single
lesion in each patient according to the procedure initially
described by Gruntzig (I) . In 40 patients, angioplasty cath-
eters of the Griintzig design (Gruentzig Dilica, United States
Catheter and Instrument) were used and in 6 patients the
Simpson-Robert angioplasty catheter (Advanced Catheter
Systems) was employed. The site of dilation was the prox-
imal left anterior descending artery (before the first septal
perforator) in 33 patients, the mid-left anterior descending
artery (from the first septal perforator to the second diagonal
branch) in 5, the proximal right coronary artery (before the
right ventricular branch) in 3, the mid-right coronary artery
(between the right ventricular and acute marginal branches)
in 4 and the left main coronary artery in I.
When their clinical condition permitted, patients under-
went treadmill exercise testing and radionuclide ventricu-
lography at rest and during exercise, and functional clas-
sification was estimated according to the Canadian Heart
Association classification (9) before and immediately after
angioplasty , and at the time of repeat angiography at 6
months and 3 years . Exercise testing was performed with
patients withdrawn from nitrates, beta-blocker and calcium
channel blocking drugs before angioplasty, except for I
patient receiving verapamil and I propranolol. All patients
were receiving aspirin (75 to 660 mg/day) and dipyridamole
(150 to 225 mg/day) before and immediately after angio-
plasty . Twenty-six patients were also taking verapamil (360
to 480 mg/day) at the time of the immediate postangioplasty
radionuclide studies and 25 at the time of the immediate
postangioplasty treadmill test. Verapamil therapy was con-
tinued for 2 to 6 months in 30 patients. Aspirin was con-
tinued until the 6 month visit in 42 patients , dipyridamole
in 39 and long-acting nitrates in 8. All medication was
discontinued at the time of the 6 month and 3 year post-
angioplasty studies except in two patients who were still
taking verapamil at the 6 month radionuclide study.
Angiography. Forty-five patients underwent left ventric-
ulography and coronary cineangiography at a mean follow-
up time of 6.8 months (range 1.5 to 12) and all 46 at a
mean follow-up time of 37.6 months (range 27.5 to 45.5).
These two follow-up studies will subsequently be referred
to as 6 month and 3 year studies. The coronary arteriograms
were read by three observers (Re, DR, RW). The pre- and
immediately postangioplasty films were interpreted un-
blinded, but the 6 month and 3 year studies were interpreted
without knowledge of the study date. The degree of diameter
obstruction in the region of dilation was read in the same
view for all four studies and by all three examiners, and the
percent patency was measured with calipers from the raw
image displayed on a Vanguard XR35 projector screen .
Because the four studies for a given patient were read as a
group, the same segment of vessel in a similar projection
was used to make the relative " normal" measurement for
each reading . The average measurement for the three readers
was then determined for each study.
Treadmill exercise tests. Graded treadmill testing was
started at a 0% grade at a speed of 2.2 mph, and every 2.5
minutes the grade was increased by 2.5 % until 12.5 minutes
had elapsed . At this point, the speed and incline continued
to be increased every 2.5 minutes from 2.2 mph at a 12%
grade to 2.7 mph at 14%; 3.1 mph at 16%; 3.5 mph at 18%;
3.9 mph at 20%; 4.7 mph at 20%; and 5.5 mph at 20%.
The tests were maximal tests; that is, they were terminated
because of 1) the onset of angina or lightheadedness, 2) the
development of sufficient dyspnea or fatigue so that the
patient did not wish to continue, or 3) the onset of significant
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Figure 1. Percentdiameterstenosis at the time of each evaluation
before and after angioplasty (PTeA). Vertical bars indicate
± I SD.
his obstruction between the 6 month and 3 year and im-
mediate and 3 year studies is the only patient who fulfills
the definition of late restenosis (>50% loss of initial im-
provement) during long-term follow-up. There is reason to
believe, however, that this development may not represent
a true late restenosis, because the patient continued to com-
plain of chest pain soon after angioplasty when narrowing
of his proximal left anterior descending artery lesion had
decreased from 54 to II %. He was recatheterized 2112
months later and the narrowing had increased to 37%. He
was maintained on verapamil for presumed vasospastic an-
gina. At 3 year follow-up, his symptoms had increased
somewhat, but he was still considered to be in class II at a
time when the stenosis was 62%. As a result of these con-
siderations, it is uncertain whether these changes occurred
within the first 3 to 9 months after angioplasty, or represent
late restenosis.
Immediately after angioplasty, two patients had obstruc-
tion at the site of dilation that measured greater than 50%
(56 and 51%, respectively). At the time of late follow-up
the lesions measured 27 and 45%, respectively, and both
patients were asymptomatic. At 3 year follow-up, one ad-
arrhythmias. Exercise duration was recorded and the elec-
trocardiogram was monitored throughout the test and for 5
minutes after the termination of exercise.
Data are included only from the 40 patients who under-
went exercise testing before coronary dilation. In four pa-
tients who had a second angioplasty because of restenosis,
the study before the first coronary dilation was used as the
control because no study was performed before the second
dilation.
Radionuclide cineangiography. Radionuclide cinean-
giography was performed at rest and during supine bicycle
exercise. The methods utilized have been described in greater
detail previously (10). Images were obtained using a mod-
ified left anterior oblique position from which global ejection
fraction was calculated. Regional wall motion of the border-
forming segments W(iS evaluated from the cineangiographic
display and of the nonborder-forming regions by inspection
of the computer-generated stroke volume image. For each
segment, wall motion was designated normal, hypokinetic,
akinetic or dyskinetic. Ejection fraction and regional wall
motion were determined at rest and during maximal exer-
cise. In all exercise studies, data were obtained at maximal
effort. Thus, in most patients, observations at follow-up
were made at a higher level of exercise compared with that
employed at baseline. Data are again included only from
the 41 patients who underwent radionuclide angiography
before angioplasty. In two patients who had a second an-
gioplasty because of restenosis, the study before the first
coronary dilation was used as the control, because no study
was performed before the second dilation.
Statistical analysis. All statistical analyses were per-
formed using analysis of variance for unbalanced data. All
results are expressed as the mean ± I SD.
Results
Angiography. Site of dilation. Angioplasty resulted
in an immediate decrease in obstruction from 66 ± 13% to
30 ± 13% (p < 0.001) (Fig. I). The absolute reductions
ranged from 9 to 81%. At 6 months and 3 years, the percent
obstruction showed a further significant decrease to 26 ±
16% (p < 0.005 versus immediate postangioplasty result)
and to 19 ± 13% (p < 0.001 versus 6 month result) (Fig.
I). Eleven patients showed clear-cut angiographic evidence
of a dissection immediately after coronary dilation in the
area of angioplasty. Comparison of the short-and long-terrn
results of angioplasty in patients with and without dissection
showed no difference in mean diameter stenosis between
the two groups at any evaluation.
The results were analyzed to determine how many pa-
tients showed a greater than 10 to 20% change in stenosis
from the immediate to 6 month, 6 month to 3 year and
immediate to 3 year postangioplasty studies (Table I). The
one patient who showed a greater than 20% worsening of
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Table 1. Change in Dilated Coronary Artery Stenoses During Follow-Up After Coronary
Angioplasty
Interval
Change in Immediately to 6 Months 6 Months to 3 Years Immediately to 3 Years
Stenoses After PTCA After PTCA After PTCA
r
Increased narrowing 7 (2) 2 (I) I (I)
2::10% (20%)
Stable 19 (37) 23 (38) 18 (32)
:s1O% (20%)
Decreased narrowing 19 (6) 20 (6) 27 (13)
2::10% (20%)
Numbers in parentheses indicate the number of stenoses with a change of at least 20%. PTCA = coronary
angioplasty.
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ditional patient, who is described in the previous paragraph,
had a narrowing at the dilation site that measured greater
than 50%.
Seven patients at the time of angioplasty had been con-
sidered to have had successful dilation (>20% absolute
reduction in the stenosis) but, during the angiographic read-
ings performed 3 years after angioplasty for this study, were
recognized to have had less than 20% reduction. Even though
these seven patients demonstrated minimal immediate im-
provement, all seven had decreased stenosis at 3 years com-
pared with that present immediately after angioplasty. Six
of the seven had a greater than 20% absolute improvement
at 3 years, compared with findings before angioplasty, and
the seventh showed 19% improvement and had a residual
28% diameter obstruction.
Sites other than those dilated. In five patients, hemo-
dynamically insignificant atherosclerotic disease progressed
to significant disease in native vessels at sites other than the
one undergoing dilation. In one additional patient, disease
progressed at a bypass anastomotic site. (Progression from
hemodynamically insignificant to significant disease was
defined in this situation as a <50% diameter narrowing
before coronary dilation progressing to a >50% narrowing
at the time of late follow-up.) In one of these patients not
only was there progression in one vessel from insignificant
to significant narrowing, causing a change in status from
double to triple vessel disease, but the two vessels that were
narrowed by more than 50% at entry progressed to total
occlusion. In another patient, the presence of intimal plaque
at entry progressed to 40 to 50% narrowing in the two vessels
not dilated. This patient had a myocardial infarction l~
months after the 3 year study. Angiography shortly after
infarction showed narrowing of more than 50% in three
vessels with no disease progression at the angioplasty site.
In all six patients with progression of disease, at least
one of the sites of progression was in the same vessel in
which angioplasty had been attempted. The progression was
at a site proximal to successful angioplasty in three, distal
in two and at a graft anastamotic lesion where dilation was
unsuccessfully attempted in one. Two patients also showed
progression of disease to significant obstruction in vessels
other than the one undergoing angioplasty.
Treadmill exercise. Before successful angioplasty, the
average exercise duration was 9.8 ± 4.4 minutes. Exercise
capacity increased significantly to 18.3 ± 4.5, 20.3 ± 4.6
Figure 2. Treadmill exercise duration at the time of each evalu-
ationbefore and afterangioplasty. Vertical bars indicate ± I SO.
The numberof patients is shown within the bars.
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Figure 3. Change in left ventricular ejection fraction (LYEF) from
rest to exercise at the time of each evaluation before and after
angioplasty. Vertical bars indicate ± I SO . The number of pa-
tients is shown in the bars.
and 18.2 ±: 4.5 minutes immediately . 6 months and 3 years
after coronary dilation respectively (Fig. 2) . Exercise was
stopped because of the development of angina in 31 of 40
test s before angioplasty, in 3 of 39 tests immediately after
angioplasty, 5 of 35 tests. 6 months after angioplasty and
in 4 of 38 tests 3 years after angioplasty . If a significant
increase in exercise capacity is arbitrarily considered to have
occurred when exercise time increased by at least 3 minutes.
then 26 of 38 patients (68%) demonstrated a sustained im-
provement in exercise capacity 3 years after angioplasty .
Radionuclide cineangiography. Mean left ventricular
ejection fraction obtained at rest was similar at all studies:
55 ±: 6% before. 54 ±: 6% immediately after. 53 ±: 6%
6 months after and 57 ±: 6% 3 years after angioplasty.
The 3 year value was significantly better than the value
immediately after (p < 0.02) and 6 months after (p = 0.00 I)
angioplasty . Wall motion abnormalities at rest were dem-
onstrated in seven patients before angioplasty: in five of
these patients . no such abnormality was appreciated in the
study performed 3 years after angioplasty. In one patient .
a rest wall motion abnormality was present at the 3 year
study that was not seen before angioplasty .
Left ventricular ejection fraction during maximal exer-
cise averaged 52 ±: 7% before. 61 ±: 7% immediately after.
59 ±: 7% 6 months after and 62 ±: 7% 3 years after an-
gioplasty. The last three values repre sent significantly better
responses (p < 0.00 I) than those of the study before an-
gioplasty. Before coronary dilation. ejection fraction de-
creased an average of 4 ±: 6% from rest to exercise . At
each subsequent study . ejection fraction increased from rest
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Figure 4. Functional classification according to the Canadian Heart
Association classification before and after angioplasty (PTCA) .
The number of patients is shown in the boxes and along the lines .
to exercise: 7 ±: 7% immediately after. 6 ±: 7% 6 months
after and 4 ±: 6% 3 years after angioplasty (Fig. 3) . All
mean follow-up changes were significantly improved (p <
0.001) compared with the preangioplasty value. Defining a
normal ejection fraction response to exercise as a 5% or
greater increase, only 7 (18%) of 39 patients had a normal
response before angioplasty. although at follow-up 23 (66%)
of 35 immediately after angioplasty. 19 (58%) of 33 at 6
months and 21 (57%) of 37 at 3 years showed a normal
response.
Th irty-one (79%) of 39 patients had abnormal wall mo-
tion with exercise before dilation; 25 (83%) of 30 patients
studied at 3 years demonstrated normal wall motion at the
late follow-up study. One patient developed an exercise wall
motion abnormality at 3 years that was not present before
angioplasty .
Functional classification (Fig. 4). Thirty-nine patients
exhibited an improvement in functional class by at least one
grade at the time of 3 year follow-up. when compared with
the classification before angioplasty . Of the 21 patients who
still had symptoms of chest pain at late follow-up, 7 had a
coronary lesion that could explain the occurrence of residual
or renewed angina. No anatomic source of the chest pain
could be identified in the remaining 14 patients, although
6 of these demonstrated exercise-induced abnormalities of
left ventricular function that were compatible with ischemia .
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Discussion
Anatomic results. The results of the present investi-
gation indicate that although the early recurrence rate after
successful angioplasty is high, namely, 17 (29%) of 59
patients, it is very unlikely for restenosis to occur over the
next 3 years after the first 9 months have elapsed. Only I
(2%) of 46 patients may have experienced recurrence of
significant obstruction beyond this time, and it is uncertain
at what point this patient's restenosis occurred. A similar
observation was made in a preliminary report by Griintzig
et al. (II), who noted 2 patients (2%) with late restenosis
among 82 patients with an average follow-up of 48 months.
The recurrences were detected at 42 and 53 months, re-
spectively, after the initial successful procedure.
Not only was there an extremely low restenosis rate after
the first 9 months of follow-up, but stenosis severity actually
decreased between the 6 month and 3 year studies: average
diameter obstruction decreased from 26 to 19% (p < 0.001),
with six patients exhibiting a greater than 20% decrease.
Stenosis severity increased by 20% in only one patient. On
the other hand, when progression of disease occurred at
sites other than where the angioplasty was performed, in
each of six patients at least one site of progression involved
the vessel that was dilated. Two of the six new significant
lesions were close enough to the angioplasty site so that it
can be inferred that they were exposed to the effects of
balloon inflation, whereas the dilation catheter traversed two
other sites and the fixed catheter tip guide may have reached
the final two locations. The failure to see any angiographic
changes in these areas immediately after angioplasty, the
fact that disease progressed in other vessels in two of the
patients and the observation that five of the new stenoses
in the dilated vessels occurred after the 6 month study all
make it unlikely that the new lesions were caused by the
procedure. This possibility cannot be excluded, howev~r,
and should be kept in mind when similar follow-up studies
are performed.
Functional results. Previous reports (2,3,5,6,8) have
established that improvement in exercise capacity, left ven-
tricular function with exercise and subjective experience of
symptoms occurs after successful angioplasty and that the
subjective improvement is maintained for up to 5 years. The
present investigation corroborates these findings, and also
demonstrates an excellent correlation between the improve-
ment in these variables and the anatomic results. Nonethe-
less, several patients had an abnormal left ventricular re-
sponse to exercise, or exercise-induced angina, without a
50% or greater diameter narrowing of any coronary artery.
If these abnormalities reflect myocardial ischemia, it is pos-
sible that we underestimated the functional importance of
the residual stenosis (12, 13), or that either large or small
vessel (14) spasm contributed to the residual functional ab-
normalities. Another consideration is that we measured only
the relative stenosis with each study and did not analyze the
site of residual obstruction for length or absolute degree of
vessel narrowing. Thus, although the percent diameter nar-
rowing may have been less than 50% and therefore desig-
nated insignificant, the length or absolute diameter or both,
of the vessel in the area of residual obstruction may have
resulted in impaired myocardial blood flow with exercise.
An alternative explanation for the evidence of reversible
ischemia without obvious anatomic cause is that these ab-
normalities do not in fact represent ischemia but are false
positive studies, perhaps due to too strict criteria for defining
normal ejection fraction responses during radionuclide ex-
ercise studies.
Conclusions. The course of coronary patency observed
after successful coronary dilation is similar to that observed
in the initial studies evaluating the patency of vein grafts
after coronary bypass surgery. Although 10 to 30% of vein
grafts are occluded at 3 to 9 month studies (15), after this
early period, stenosis rates over the next 3 to 4 years are
very low. Whether, as with vein grafts (16), stenosis rates
in the dilated vessels begin increasing after 5 to 10 years
remains to be determined. Regardless of the fate of the
dilated vessels after 5 to 10 years, the excellent 3 year results
of coronary angioplasty appear to justify its being considered
the treatment of choice for those lesions that are approach-
able by this procedure, as long as the risk of such an in-
tervention is not believed to surpass that of coronary bypass
surgery or medical treatment.
We are indebted to Beverly B. Barber. RN. Cecelia A. Bergamo. RN and
Steven W. Galyon. RN for their assistance in this study.
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